Evidence map›Paper›PMID 41513952›Full record

ArticleScientific reports2026

Explainable AI with EDA for V2I path loss prediction.

Mongi Ben Ameur, Jalel Chebil, Mohamed Hadi Habaebi, Jamel Bel Hadj Tahar, Md Rafiqul Islam, Abdul Manan Sheikh

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mongi Ben AmeurNOCCS Laboratory, University of Sousse, Sousse, Tunisia.
Jalel ChebilNOCCS Laboratory, University of Sousse, Sousse, Tunisia.
Mohamed Hadi HabaebiDepartment of ECE, International Islamic University Malaysia, Kuala Lumpur, Malaysia. habaebi@iium.edu.my.
Jamel Bel Hadj TaharNOCCS Laboratory, University of Sousse, Sousse, Tunisia.
Md Rafiqul IslamDepartment of ECE, International Islamic University Malaysia, Kuala Lumpur, Malaysia.
Abdul Manan SheikhDepartment of EECS, College of Engineering, A'Sharqiyah University, 400, Ibra, Oman. abdul.manan@asu.edu.om.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate pathloss (PL) prediction is essential for reliable Vehicle-to-Infrastructure (V2I) communication, particularly in dense urban environments characterized by mobility, multipath effects, and complex street geometries. Traditional empirical models often fail to capture these variations, while black-box machine learning (ML) methods lack transparency, limiting their suitability for safety-critical V2X applications. This paper proposes a fully explainable V2I PL prediction framework that integrates Exploratory Data Analysis (EDA), optimized Kalman filtering, and inherently interpretable ML models, including Explainable Boosting Machines (EBM), Generalized Additive Models (GAM), and Generalized Neural Additive Models (GNAM). The framework is validated using a large-scale dataset of 24 heterogeneous urban scenarios and evaluated through 5-fold cross-validation and multi-seed runs. Results show that interpretable models offer competitive accuracy compared to black-box approaches while providing robust global and local explanations of feature contributions. The study also discusses computational considerations, real-time feasibility, and ethical aspects relevant to practical V2X deployment. The proposed framework demonstrates high potential for transparent and trustworthy PL prediction in future 5G/6G V2I systems.

Indexed as

Channel modelingExplainable AI (ExAI)Path loss predictionV2I communications

Identifiers

PMID41513952
PMCPMC12877196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.